Skip to main content
. Author manuscript; available in PMC: 2019 Jul 12.
Published in final edited form as: Inflamm Bowel Dis. 2018 Jul 12;24(8):1840–1848. doi: 10.1093/ibd/izy083

Figure 2:

Figure 2:

Time to cessation of anti-TNF biologic therapy, stratified by risk burden of 12 SNPs associated with durable response. Increasing quartile indicates increasing genetic burden for durable response